NAPSRx

The concept behind gene therapy is simple: deliver a healthy gene to compensate for one that is mutated.

Results of a Phase III clinical trial showed that a simple drug regimen of two anti-clotting drugs - clopidogrel and aspirin - lowered the risk of stroke by almost one-third, compared to the standard therapy of aspirin alone.

The U.S. Food and Drug Administration has approved Tivicay (dolutegravir), a new drug to treat HIV-1 infection.

A team of researchers from UC Davis, UC San Diego and other institutions has identified a key mechanism behind aggressive prostate cancer.

Ottawa researchers have developed unique virus-derived particles that can kill human blood cancer cells in the laboratory and eradicate the disease in mice with few side effects.

Many drugs such as agents for cancer or autoimmune diseases have nasty side effects because while they kill disease-causing cells, they also affect healthy cells. Now a new study has demonstrated a technique for developing more targeted drugs.

Researchers have developed a drug delivery technique for diabetes treatment in which a sponge-like material surrounds an insulin core.

The AIDS virus can be used to treat two severe hereditary diseases. After an Italian scientist's "stroke of genius" in 1996, and after years of promising results in the laboratory, double official recognition a scientific journals has now arrived.

Chemically modified inhibitors of the COX-2 enzyme relieve anxiety behaviors in mice by activating natural "endocannabinoids" without gastrointestinal side effects

The future is looking good for drugs designed to combat Alzheimer's disease.Scientists have unveiled how two classes of drug compounds currently in clinical trials work to fight the disease.